High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia--preliminary clinical and pharmacological data of a randomized comparison.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples